カテゴリー： Grand View Research, 世界

インフルエンザ診断の世界市場分析：製品別（インスリン注射器、インスリンペン、インスリンポンプ、インスリン注射器）、エンドユーザー別（病院、ホームケア、援助生活センター、養護施設）、セグメント予測、2014-2025

【英語タイトル】Insulin Delivery Devices Market Analysis By Product (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Injectors), By End Use (Hospitals, Homecare, Assisted Living Centers, & Nursing Homes), And Segment Forecasts, 2014-2025

Grand View Researchが出版した調査資料（GVIEW707439）・商品コード：GVIEW707439
・発行会社（調査会社）：Grand View Research
・発行日：2016年11月7日
・ページ数：80
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD4,950 ⇒換算￥559,350見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算￥898,350見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算￥1,124,350見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日～2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートでは、インフルエンザ診断の世界市場について調査・分析し、インフルエンザ診断の世界市場動向、インフルエンザ診断の世界市場規模、市場予測、セグメント別インフルエンザ診断市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The insulin delivery devices market is expected to reach USD 19.8 billion by 2025, according to a new report by Grand View Research, Inc. The global industry is estimated to witness a high growth during the forecast period from 2016 to 2025. Rapidly increasing number of diabetics coupled with the escalating attention around diabetes care is a major factor propelling the market.
Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices is a major factor restraining the growth of this industry.

Further Key Findings from the Study Suggest:

The insulin pens segment was the largest revenue-generating category of this market in 2015. The pen is equipped with self-contained cartridges and offers ease in handling & less pain while injecting insulin. Advantages of these pen devices over other products are resulting in its growing popularity, thus serving as a vital factor in contributing to the sector’s highest share in this market.

Homecare is estimated to be the largest shareholder and the fastest growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients.

North America is the leading regional sector and accounted for the largest revenue share in 2015 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting the market growth.

The Asia Pacific region is anticipated to be the fastest growing market during the forecast period. The high prevalence rate of diabetes in the Asian countries, such as China and India, is a major factor contributing to market expansion in this region.

Some key players serving this vertical include Novo Nordisk A/S; Sanofi; Eli Lilly and Company; Medtronic; Becton, Dickinson and Company; Abbott; and F. Hoffmann-La Roche Ltd.

【レポートの目次】

Table of Content

Chapter 1. Research Methodology
1.1. Information Procurement
1.2. Data Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Insulin delivery devices: Market dynamics
3.2.1. Market driver analysis
3.2.2. Market restraints analysis
3.3. Key Opportunities Prioritized
3.4. Insulin delivery devices – SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.5. Industry Analysis – Porter’s
3.6. Competitive Landscape: Market Position Analysis
Chapter 4. Market Categorization 1: Product Estimates & Trend Analysis
4.1. Insulin delivery devices: Product Movement Analysis
4.2. Insulin syringes
4.2.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
4.3. Insulin pens
4.3.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
4.4. Insulin pumps
4.4.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
4.5. Insulin injectors
4.5.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 5. Market Categorization 2: By End-Use, Estimates & Trend Analysis
5.1. Insulin delivery devices: Technology Movement Analysis
5.2. Hospital
5.2.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
5.3. Homecare
5.3.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
5.4. Others
5.4.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 6. Market Categorization 5: Regional Estimates & Trend Analysis
6.1. Insulin Delivery Devices Market Share (%) Analysis, by Region 2016 & 2025
6.2. North America
6.2.1. U.S.
6.2.1.1. U.S. insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.2.1.2. U.S. insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.2.2. Canada
6.2.2.1. Canada insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.2.2.2. Canada insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.3. Europe
6.3.1. Germany
6.3.1.1. Germany insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.3.1.2. Germany insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.3.2. UK
6.3.2.1. UK insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.3.2.2. UK insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.4. Asia Pacific
6.4.1. China
6.4.1.1. China insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.4.1.2. China insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.4.2. India
6.4.2.1. India insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.4.2.2. India insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.5. Latin America
6.5.1. Brazil
6.5.1.1. Brazil insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.5.1.2. Brazil insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.5.2. Mexico
6.5.2.1. Mexico insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.5.2.2. Mexico insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.6. MEA
6.6.1. South Africa
6.6.1.1. South Africa insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.6.1.2. South Africa insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.6.2.2. Saudi Arabia insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Profiles
7.2. Novo Nordisk A/S
7.2.1. Company overview
7.2.2. Financial performance
7.2.3. Product benchmarking
7.2.4. Strategic initiatives
7.3. Sanofi
7.3.1. Company overview
7.3.2. Financial performance
7.3.3. Product benchmarking
7.3.4. Strategic initiatives
7.4. Eli Lilly and Company
7.4.1. Company overview
7.4.2. Financial performance
7.4.3. Product benchmarking
7.4.4. Strategic initiatives
7.5. Biocon Ltd.
7.5.1. Company overview
7.5.2. Financial performance
7.5.3. Product benchmarking
7.5.4. Strategic initiatives
7.6. Ypsomed AG
7.6.1. Company overview
7.6.2. Financial performance
7.6.3. Product benchmarking
7.6.4. Strategic initiatives
7.7. Wockhardt Ltd.
7.7.1. Company overview
7.7.2. Financial performance
7.7.3. Product benchmarking
7.7.4. Strategic initiatives
7.8. Medtronic
7.8.1. Company overview
7.8.2. Financial performance
7.8.3. Product benchmarking
7.8.4. Strategic initiatives
7.9. Abbott Laboratories
7.9.1. Company overview
7.9.2. Financial performance
7.9.3. Product benchmarking
7.9.4. Strategic initiatives
7.10. F. Hoffmann-La Roche, Ltd.
7.10.1. Company overview
7.10.2. Financial performance
7.10.3. Product benchmarking
7.10.4. Strategic initiatives

List of Figures

1. Market summary
2. Market trends & outlook
3. Insulin delivery devices: Market segmentation
4. Market driver relevance analysis (Current & future impact)
5. Penetration & growth prospect mapping
6. SWOT analysis, by factor (Political & legal, economic and technological)
7. Insulin delivery devices Porter’s analysis
8. Insulin delivery devices market: Product outlook key takeaways
9. Insulin delivery devices market: Product movement analysis
10. Global insulin syringes market, 2014 - 2025 (USD Million)
11. Global insulin pumps market, 2014 - 2025 (USD Million)
12. Global insulin pens market, 2014 - 2025 (USD Million)
13. Global insulin injectors market, 2014 - 2025 (USD Million)
14. Insulin delivery devices market: End-use outlook key takeaways
15. Insulin delivery devices market: End-use movement analysis
16. Global hospitals market, 2014 - 2025 (USD Million)
17. Global homecare market, 2014 - 2025 (USD Million)
18. Global other market, 2014 - 2025 (USD Million)
19. Regional market place: Key takeaways
20. Regional outlook, 2016 & 2025

List of Tables

1. North America insulin delivery devices market, by country, 2014 - 2025 (USD Million)
2. North America insulin delivery devices market, by product, 2014 - 2025 (USD Million)
3. North America insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
4. U.S. insulin delivery devices market, by product, 2014 - 2025 (USD Million)
5. U.S. insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
6. Canada insulin delivery devices market, by product, 2014 - 2025 (USD Million)
7. Canada insulin delivery devices market, by end user, 2014 - 2025 (USD Million)
8. Europe insulin delivery devices market, by country, 2014 - 2025 (USD Million)
9. Europe insulin delivery devices market, by product, 2014 - 2025 (USD Million)
10. Europe insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
11. Germany insulin delivery devices market, by product, 2014 - 2025 (USD Million)
12. Germany insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
13. UK insulin delivery devices market, by product, 2014 - 2025 (USD Million)
14. UK insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
15. Asia Pacific insulin delivery devices market, by country, 2014 - 2025 (USD Million)
16. Asia Pacific insulin delivery devices market, by product, 2014 - 2025 (USD Million)
17. Asia Pacific insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
18. China insulin delivery devices market, by product, 2014 - 2025 (USD Million)
19. China insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
20. India insulin delivery devices market, by product, 2014 - 2025 (USD Million)
21. India insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
22. Latin America insulin delivery devices market, by country, 2014 - 2025 (USD Million)
23. Latin America insulin delivery devices market, by product, 2014 - 2025 (USD Million)
24. Latin America insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
25. Brazil insulin delivery devices market, by product, 2014 - 2025 (USD Million)
26. Brazil insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
27. Mexico insulin delivery devices market, by product, 2014 - 2025 (USD Million)
28. Mexico insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
29. MEA insulin delivery devices market, by country, 2014 - 2025 (USD Million)
30. MEA insulin delivery devices market, by product, 2014 - 2025 (USD Million)
31. MEA insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
32. South Africa insulin delivery devices market, by product, 2014 - 2025 (USD Million)
33. South Africa insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
34. Saudi Arabia insulin delivery devices market, by product, 2014 - 2025 (USD Million)
35. Saudi Arabia insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)



★調査レポート[インフルエンザ診断の世界市場分析：製品別（インスリン注射器、インスリンペン、インスリンポンプ、インスリン注射器）、エンドユーザー別（病院、ホームケア、援助生活センター、養護施設）、セグメント予測、2014-2025] (コード：GVIEW707439)販売に関する免責事項を必ずご確認ください。
★調査レポート[インフルエンザ診断の世界市場分析：製品別（インスリン注射器、インスリンペン、インスリンポンプ、インスリン注射器）、エンドユーザー別（病院、ホームケア、援助生活センター、養護施設）、セグメント予測、2014-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 負圧創傷治療の世界市場分析：製品別（従来型、シングルユース）、傷別（糖尿病性足潰瘍、圧迫潰瘍、静脈脚潰瘍、火傷）、エンドユーザー別（病院、ホームケア）、セグメント予測、2014-2025
  • 滅菌装置の鍛造品の世界市場分析：技術別（熱、低温、ろ過、放射線、液体）、エンドユーザー別（病院、医薬品、医療機器、臨床検査室）、セグメント予測、2014 – 2025
  • クリルオイルの世界市場分析：製品別（液体、錠剤（ソフトゲル、カプセル））、エンドユーザー別（食物サプリメント、機能性食品および飲料、医薬品、動物用食品およびペットフード）、地域別、セグメント予測、2014-2025
  • パルス酸素濃度計の世界市場の規模と予測：タイプ別（指先、ハンドヘルド、その他）、エンドユーザー別（病院・医療施設、ホームケア）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA）、セグメント予測、2013-2025
  • 航空用プラスチックの世界市場分析：用途別（航空機構造、構成品、客室内装、推進システム、衛星）、エンドユーザー別、セグメント予測 2014-2025
  • ユーバイオティクスの世界市場分析：製品別（プロバイオティクス、プレバイオティクス、有機酸、エッセンシャルオイル）、形状別（液体、固体）、用途別（腸の健康、免疫、産出）、エンドユーザー別（ウシ、家禽、豚、水産物）、セグメント予測、2014-2025
  • 環境健康と安全の世界市場分析：製品別（ソフトウェア、ハードウェア）、用途別（医療廃棄物管理、産業廃棄物管理、廃水管理）、エンドユーザー別、セグメント予測、2014-2025
  • 膨張ポリプロピレン（EPP）発泡体の世界市場分析：製品別（低密度、中密度、高密度）、エンドユーザー別（自動車、梱包、消費財、その他）、セグメント予測、2014-2025
  • 建築用断熱材の世界市場分析：製品別（グラスウール、ミネラルウール、EPS、XPS）、用途別（屋根、壁、床）、エンドユーザー別（住居、非住居）、動向･動態、競争戦略、セグメント予測、2014-2025
  • 整形外科骨セメントの世界市場分析：エンドユーザー別（病院、外来手術センター、専門診療所）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA）、セグメント予測、2014-2025

    • ◆H&Iグローバルリサーチのお客様（例）◆